Inventor · disambiguated record
Stephen B. Howell
Also filed as: HOWELL STEPHEN · HOWELL STEPHEN B
16 granted patents·3 pending applications·547 citations·filing 1990–2024
94Inventor score
Top patents by PatentIndex Score
19 records- 0196US5723147AMultivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochlorideDEPOTECH CORP·Filed 1995·Granted Mar 3, 1998·219 cites·16 claims
- 0287US5455044AMethod for treating neurological disordersDEPOTECH CORP·Filed 1993·Granted Oct 3, 1995·78 cites·4 claims
- 0382US6071534AMultivesicular liposomes with controlled release of active agents encapsulated in the presence of a hydrochlorideSKYEPHARMA INC·Filed 1998·Granted Jun 6, 2000·66 cites·39 claims
- 0479US5807572AMultivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochlorideDEPOTECH CORP·Filed 1995·Granted Sep 15, 1998·50 cites·40 claims
- 0579US5576018AMethod for treating neurological disordersDEPOTECH CORP·Filed 1995·Granted Nov 19, 1996·52 cites·5 claims
- 0678US11193117B2Cell-targeted cytotoxic constructsRES FOUND DEV·Filed 2017·Granted Dec 7, 2021·2 cites·5 claims
- 0777US2024229003A1Cell-targeted cytotoxic constructsRES FOUND DEV·Filed 2024·Application pending·0 cites
- 0870US11913043B2Cell-targeted cytotoxic constructsRES FOUND DEV·Filed 2021·Granted Feb 27, 2024·0 cites·15 claims
- 0968US6344324B2Quantification of cellular injury using expression of a fluorescent protein under the control of the GADD153 promoterRES DEV FOUNDATION·Filed 2000·Granted Feb 5, 2002·12 cites·8 claims
- 1064US2024269303A1Cell targeting constructs and uses thereofRES FOUND DEV·Filed 2023·Application pending·0 cites
- 1160US5844001ACombination platinum chemotherapeutic/antiestrogen therapy for human cancersRES DEV FOUNDATION·Filed 1994·Granted Dec 1, 1998·28 cites·1 claims
- 1255US5770430ACellular injury response element and uses thereofRES DEV FOUNDATION·Filed 1996·Granted Jun 23, 1998·11 cites·16 claims
- 1354US5434046ADiagnostic assay based on cis-plain drug resistance geneUNIV CALIFORNIA·Filed 1993·Granted Jul 18, 1995·15 cites·2 claims
- 1448US8575359B2Acid-sensitive linkers for drug deliveryYANG JERRY·Filed 2007·Granted Nov 5, 2013·0 cites·6 claims
- 1540US2006019268A1Molecular markers of cisplatin resistance in cancer and uses thereofRES DEV FOUNDATION·Filed 2005·Application pending·0 cites
- 1632US5597798ATaxol and epidermal growth factor used to enhance treatment of ovarian cancerUNIV CALIFORNIA·Filed 1994·Granted Jan 28, 1997·5 cites·1 claims
- 1732US5252342AEnhancement of anti-neoplastic drug efficacy using EGFUNIV CALIFORNIA·Filed 1990·Granted Oct 12, 1993·5 cites·1 claims
- 1829US5928926AIsolation and cloning of the human ARSA-I gene and uses thereofRES DEV FOUNDATION·Filed 1996·Granted Jul 27, 1999·4 cites·7 claims
- 1920US6288111B1Combination cisplatin/tamoxifen therapy for human cancersRES DEV FOUNDATION·Filed 1995·Granted Sep 11, 2001·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Stephen B. Howell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →